Rheumatainment Podcast
1) Covid The 5th Wave Worldwide, Medicine Discovery with a Novel Target for Pain, Larkin ...
Dr. George Munoz explores a variety of topics, including the COVID 5th wave, the Larkin Rheumatology training, and Larkin Hospital.
2) Rheuminations Updates on Covid Boosters, Diet Importance in Covid, and Rheumatology Updates ...
Dr. George Munoz discusses updates on Covid Boosters, diet importance during Covid, Rheumatology updates on testing, and Best of Class Nutraceuticals.
3) Chronic Pain Management
Dr. George Munoz discusses chronic pain management and a recent study that examined these management options.
4) Update on COVID-19 Vaccines, Boosters, and Masks
Dr. George Munoz provides an update on COVID-19 vaccines, boosters, and the efficacy of masks.
5) Disparity of COVID19 Morbidity & Mortality in Hispanics and African Americans.
Disparity of COVID19 Morbidity & Mortality in Hispanics and African Americans....EXPLORING THE WHY and the ROLE OF INTEGRATIVE MEDICINE IN ADDRESSING THIS INEQUITY.
Disparity of COVID19 Morbidity & Mortality in Hispanics and African Americans.
0:00 | Jun 29th, 2021
6) FSR LECTURES AND TOPICS
Dr. George Munoz discusses the 2nd annual Integrative Rheumatology Pre-Conference for the Florida Society of Rheumatology.
7) OASIS HEALTH NUTRACEUTICALS FOR INFLAMMATORY RHEUMATOLOGY
Dr. George Munoz discusses Oasis Health's Nutraceutical product line and how it focuses on inflammatory rheumatic disorders.
8) The Role of Diet in Autoimmune Diseases
Dr. George Munoz and Isabella Leoni discuss Functional medicine, the role it plays in Arthritic therapy, and how an anti-inflammatory lifestyle can help you manage Arthritis and live a more pain-free ...Show More
9) FDA WARNINGS ABOUT XELJANX (ARTHRITIS MEDICATION)
Dr. George Munoz discusses FDA warnings about a powerful Arthritis medication (Xeljanx) and risks of both heart disease and possibly cancer risk. What does it mean for patients and physicians?
10) Covid-19 Vaccines
In today's episode, Dr. George Munoz discusses Covid-19 vaccines and what we know about their efficacy as well as their rollout.